Friday 6 November 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.

Revenue: +8.45%
EPS: +19.4%
Free cash flow: −0.16%
Total debt: −1.06%

Quarter to September 2026, against a year earlier

461.70 1.42 +0.31%

Follow AMGN

Alert me

Market cap: $248.8B
P/E: 26.6×
Fwd P/E: 29.6×
Dividend yield: 2.15%
F-score: 7/9
Altman Z: 1.69
Beneish M: −2.27
Dividend safety: 56/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	24.25	22.33	24.30	22.84	+8 more quarters Free account
P/S ratio Full definition →	5.86	5.13	5.10	4.79
P/FCF ratio Full definition →	24.93	20.07	23.28	22.97
P/Operating CF Full definition →	53.77	48.86	86.80	109.85
P/B ratio Full definition →	19.51	16.73	20.67	20.34
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	6.91	6.27	6.32	6.03
EV/EBITDA Full definition →	16.30	14.48	14.83	14.34
EV/Operating CF Full definition →	22.34	19.14	21.87	22.25
EV/FCF Full definition →	29.39	24.52	28.82	28.90
Quick Ratio Full definition →	1.01	0.95	0.85	0.73
Current Ratio Full definition →	1.48	1.37	1.26	1.14
Net Debt/EBITDA Full definition →	0.00	9.36	11.97	11.81
Debt/Assets Full definition →	56.23%	59.92%	61.97%	60.28%
Debt/Equity Full definition →	3.76	4.90	6.24	6.31
Asset Turnover Full definition →	0.42	0.42	0.41	0.40
Operating CF/Net income Full definition →	1.10	1.69	1.20	1.20
Capex/Depreciation Full definition →	0.00	(0.46)	(0.64)	(0.57)
Interest Coverage Full definition →	5.68	5.22	4.06	4.17
Research and Development Expense of Revenue Full definition →	20.37%	18.58%	19.95%	21.71%
Selling, General and Administrative Expense of Revenue Full definition →	16.21%	17.36%	18.59%	19.79%
Intangible Assets out of Total Assets Full definition →	0.40	0.41	0.43	0.45
Share Based Compensation of Revenue Full definition →	0.00%	1.64%	0.87%	1.27%
Graham Net Nets Full definition →	(0.21)	(0.25)	(0.27)	(0.30)
Graham Number Full definition →	0.00	88.88	74.46	72.03
Earnings Yield Full definition →	4.12%	4.48%	4.12%	4.38%
Free Cash Flow Yield Full definition →	4.01%	4.98%	4.30%	4.35%
Revenue per Share Full definition →	19.16	18.62	15.96	18.34
Operating CF per Share Full definition →	7.84	7.41	4.05	2.98
Capex per Share Full definition →	0.00	(0.95)	(1.32)	(1.19)
Free Cash Flow per Share Full definition →	7.84	6.46	2.74	1.79
Cash per Share Full definition →	24.38	25.91	22.29	16.97
Shareholders Equity per Share Full definition →	26.53	21.64	17.02	16.09
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	26.53	21.64	17.02	16.09
Free Cash Flow Full definition →	4,241.00	3,489.00	1,477.00	961.00
Working Capital Full definition →	11,132.00	9,459.00	6,520.00	3,568.00
Capital Expenditures Full definition →	(587.00)	(513.00)	(712.00)	(642.00)
Net Current Asset Value Full definition →	(47,333.00)	(48,990.00)	(51,839.00)	(52,871.00)
EV/EBIT Full definition →	21.32	20.90	22.26	24.40
Capex to Sales Full definition →	0.00	0.05	0.08	0.07
Price to Operating Income Full definition →	18.08	17.11	17.98	19.39
Other line items
Average Receivables Full definition →	9,421.50	9,464.00	8,635.00	8,176.00
Average Payables Full definition →	11,835.50	2,937.50	2,670.50	2,137.50
Average Inventory Full definition →	6,367.50	6,401.50	6,457.50	6,611.50
Average Assets Full definition →	93,094.50	91,768.00	90,935.50	91,212.50
Average Common Equity Full definition →	11,985.50	9,558.00	7,698.50	7,267.50

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly